MSTN and cancer: Furthermore, myostatin and activin overproduction, nuclear factor-κB (NF-κB)-evoked inflammation, impaired insulin-like growth factor-1 (IGF-1)-induced protein synthesis in the host, and the interactions between the tumor and host systems all contribute to the development of cancer cachexia-associated muscle atrophy [8, 9].